Reduced radiostrontium absorption in a human subject treated with composite treatment for mixed fission product contamination.
D000328:Adult; D000464:Alginates / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005295:Ferrocyanides / Q000627:therapeutic use*; D020723:Glucuronic Acid; D006603:Hexuronic Acids; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D009680:Nuclear Fission; D004369:Pentetic Acid / Q000627:therapeutic use*; D011193:Potassium Iodide / Q000627:therapeutic use*; D013326:Strontium Radioisotopes / Q000378:metabolism*
D000464:Alginates; D005295:Ferrocyanides; D006603:Hexuronic Acids; D013326:Strontium Radioisotopes; D011193:Potassium Iodide; D004369:Pentetic Acid; D020723:Glucuronic Acid; C000170:ferric ferrocyanide